20358587 |
Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations
Sampath, S,
Lacassie, Y,
Tidyman, WE,
Bale, SJ,
Peltier, HM,
Estep, AL,
Rauen, KA
|
Am. J. Med. Genet. A |
2010 |
7651428 |
RAS signalling is abnormal in a c-raf1 MEK1 double mutant
Stone, JC,
Agellon, S,
Bottorff, D,
Stang, S
|
Mol. Cell. Biol. |
1995 |
24241536 |
High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias
Waterfall, JJ,
Pineda, M,
Roth, L,
Davis, SR,
Kreitman, RJ,
Killian, JK,
Meltzer, PS,
Arons, E,
Abaan, OD,
Walker, RL
|
Nat. Genet. |
2014 |
18632602 |
Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma
Ladanyi, M,
Gong, Y,
Mardis, ER,
Rusch, VW,
Ding, L,
Levine, R,
McLellan, MD,
Chitale, D,
Marks, JL,
Michel, K,
Golas, B,
Thomas, RK,
Solit, D,
Kasai, Y,
Wilson, RK,
Pao, W
|
Cancer Res. |
2008 |
24265153 |
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Taylor-Weiner, A,
Gutzmer, R,
Rosenberg, M,
Treacy, DJ,
Goldinger, SM,
Gogas, HJ,
Dermatologic Cooperative Oncology Group of Germany (DeCOG), -,
Van Allen, EM,
Garraway, LA,
Farlow, D,
Trefzer, U,
Egberts, F,
Place, CS,
McKenna, A,
Gabriel, SB,
Schadendorf, D,
Hodis, E,
Carter, SL,
Kryukov, GV,
Wagle, N,
Whittaker, S,
Johannessen, CM,
Hassel, JC,
Weide, B,
Berking, C,
Loquai, C,
Zimmer, L,
Getz, G,
Hillen, U,
Ugurel, S,
Goetz, EM,
Cibulskis, K,
Sucker, A
|
Cancer Discov |
2014 |
25435214 |
Targeting RAS-ERK signalling in cancer: promises and challenges
Poulikakos, PI,
Samatar, AA
|
Nat Rev Drug Discov |
2014 |
22197931 |
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Xenarios, I,
Antonarakis, SE,
Guipponi, M,
Jongeneel, CV,
Rimoldi, D,
Speiser, D,
Muehlethaler, K,
Michielin, O,
Zoete, V,
Bukach, O,
Harshman, K,
Halazonetis, TD,
Nikolaev, SI,
Gehrig, C,
Stevenson, BJ,
Robyr, D,
Beckmann, JS,
Iseli, C,
Valsesia, A
|
Nat. Genet. |
2011 |
23875798 |
The RASopathies
Rauen, KA
|
Annu Rev Genomics Hum Genet |
2013 |
25182392 |
The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes
Obersztyn, E,
Bezniakow, N,
Gos, M
|
Dev Period Med |
2014 |
25049390 |
Next-generation sequencing identifies rare variants associated with Noonan syndrome
Reid, JG,
Fernandez, M,
Neel, BG,
Muzny, DM,
Yung, CK,
Kucherlapati, R,
Yu, HW,
Chen, PC,
Peltekova, VD,
Gibbs, RA,
Tworog-Dube, E,
Roberts, AE,
Yin, J,
McPherson, JD,
Stein, L,
Yuan, T,
Trinh, QM,
Morgan, MB
|
Proc. Natl. Acad. Sci. U.S.A. |
2014 |
18413255 |
Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome
Rodriguez-Viciana, P,
Rauen, KA
|
Meth. Enzymol. |
2008 |
21383288 |
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling
Pochanard, P,
Hahn, WC,
Emery, C,
Kehoe, SM,
Davis, MJ,
Meyerson, M,
Sawyer, A,
Berger, MF,
Macconaill, LE,
Wagle, N,
Garraway, LA,
Johannessen, CM
|
J. Clin. Oncol. |
2011 |
18060073 |
Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy
McCormick, F,
Palmer, C,
Estep, AL,
Rauen, KA
|
PLoS ONE |
2007 |